HK1014554A1 - A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins - Google Patents

A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins

Info

Publication number
HK1014554A1
HK1014554A1 HK98115869A HK98115869A HK1014554A1 HK 1014554 A1 HK1014554 A1 HK 1014554A1 HK 98115869 A HK98115869 A HK 98115869A HK 98115869 A HK98115869 A HK 98115869A HK 1014554 A1 HK1014554 A1 HK 1014554A1
Authority
HK
Hong Kong
Prior art keywords
proteins
grb
tyrosine
tyrosine kinase
cloning method
Prior art date
Application number
HK98115869A
Inventor
Joseph Schlessinger
Benjamin L Margolis
Edward Y Skolnik
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of HK1014554A1 publication Critical patent/HK1014554A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A novel expression cloning method is provided for the detection, identification and purification of target proteins capable of binding at least to a tryosine-phosphorylated domain of a eukaryotic tyrosine kinase using novel peptide probes comprising an amino acid sequence substantially corresponding to a portion of a tyrosine-phosphorylated domain of a tyrosine kinase. The probe has at least one phosphorlated tyrosine residue and may be detectably labeled. Also disclosed is a method for preparing the probes a method for mapping to a chormosome a gene encoding a protein capable of binding to tyrosine-phosphorylated domains of tyrosine kinases, and a method for purifiying such a protein with the probe. Non-limiting examples of novel proteins discovered using the above cloning method include GRB-1, GRB-2, GRB-3, GRB-4 and GRB-7, as well as nucleic acid encoding these proteins, and methods for detecting these proteins are also provided.
HK98115869A 1991-01-18 1998-12-28 A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins HK1014554A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64323791A 1991-01-18 1991-01-18
PCT/US1992/000434 WO1992013001A1 (en) 1991-01-18 1992-01-17 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS

Publications (1)

Publication Number Publication Date
HK1014554A1 true HK1014554A1 (en) 1999-09-30

Family

ID=24579945

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115869A HK1014554A1 (en) 1991-01-18 1998-12-28 A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins

Country Status (12)

Country Link
US (3) US5434064A (en)
EP (1) EP0567567B1 (en)
JP (2) JP3462498B2 (en)
AT (1) ATE187772T1 (en)
AU (1) AU667803B2 (en)
CA (1) CA2100860C (en)
DE (1) DE69230433D1 (en)
HK (1) HK1014554A1 (en)
IE (1) IE920151A1 (en)
MX (1) MX9200246A (en)
PT (1) PT100037B (en)
WO (1) WO1992013001A1 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677421A (en) * 1991-01-18 1997-10-14 New York University Target proteins for eukaryotic tyrosine kinases
EP0567567B1 (en) * 1991-01-18 1999-12-15 New York University A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
US5667980A (en) * 1991-10-31 1997-09-16 Mount Sinai Hospital Corporation Method for assaying for a substance that affects an SH2 phosphorylated ligand regulatory system
US5378809A (en) * 1992-08-25 1995-01-03 The United States Of America As Represented By The Department Of Health And Human Services Polynucleotides and substrate for the epidermal growth factor receptor kinase (eps8)
US5459036A (en) * 1993-03-19 1995-10-17 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Extracellular signal-regulated kinase, sequences, and methods of production and use
FR2710074B1 (en) 1993-09-15 1995-12-08 Rhone Poulenc Rorer Sa GRB3-3 gene, its variants and their uses.
WO1995024915A1 (en) * 1994-03-17 1995-09-21 National Jewish Center For Immunology And Respiratory Medicine Product and process for regulating signal transduction pathways
US5541109A (en) * 1994-04-19 1996-07-30 Rhone-Poulenc Rorer Pharmaceuticals Inc. Expression cloning of c-src SH3-domain binding proteins
US5612471A (en) * 1994-05-25 1997-03-18 The Regents Of The University Of California Nematode-induced genes in tomato
US5650293A (en) * 1994-06-10 1997-07-22 Joslin Diabetes Center, Inc. Nucleic acid encoding pp60PIK and the methods of making pp60PIK
US5744313A (en) * 1994-12-09 1998-04-28 The Regents Of The University Of California Assay employing novel protein domain which binds tyrosine phosphorylated proteins
US6280964B1 (en) 1995-04-14 2001-08-28 The Regents Of The University Of California Binding sites for phosphotyrosine binding domains
US6171800B1 (en) * 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
US6423824B1 (en) * 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
EP0871648A1 (en) * 1995-09-15 1998-10-21 Merck & Co., Inc. A high throughput assay using fusion proteins
US5783398A (en) * 1995-09-15 1998-07-21 Merck & Co., Inc. High throughput assay using fusion proteins
US5895813A (en) * 1995-10-13 1999-04-20 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Diagnosis and treatment of TKA-1 related disorders
US5945523A (en) * 1995-10-13 1999-08-31 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Diagnosis and treatment of TKA-1 related disorders
US5922842A (en) * 1995-10-13 1999-07-13 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Tyrosine kinase associated polypeptides
US6028053A (en) * 1995-10-27 2000-02-22 Mount Sinai Hospital Corporation Peptide inhibitors of a phosphotyrosine-binding domain containing protein
WO1997020573A1 (en) * 1995-12-04 1997-06-12 Smithkline Beecham Corporation Growth factor receptor-binding protein 2 homolog
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
US5981220A (en) * 1996-03-27 1999-11-09 Human Genome Sciences, Inc. Epidermal differentiation factor
EP0898617A1 (en) * 1996-05-06 1999-03-03 Novo Nordisk A/S MUTANT cDNA ENCODING THE p85$g(a) SUBUNIT OF PHOSPHATIDYLINOSITOL 3-KINASE
AU6450696A (en) * 1996-07-09 1998-02-02 President And Fellows Of Harvard College Growth factor receptor-binding insulin receptor
US5840536A (en) * 1996-07-09 1998-11-24 Dunnington; Damien J. Growth factor receptor-binding insulin receptor
US5942415A (en) * 1996-09-13 1999-08-24 Schraven; Burkhart SKAP55 compositions and methods of use therefor
US7078375B1 (en) * 1996-10-25 2006-07-18 Peter Mose Larsen Diabetes-mediating proteins and therapeutic uses thereof
WO1998021585A1 (en) 1996-11-15 1998-05-22 Cornell Research Foundation, Inc. Activated ras interaction assay
US5955277A (en) * 1997-05-05 1999-09-21 Novo Nordisk A/S Mutant cDNA encoding the p85α subunit of phosphatidylinositol 3-kinase
US6312941B1 (en) 1997-11-26 2001-11-06 The Regents Of The University Of Michigan Compositions and methods for identifying signaling pathway agonists and antagonists
US6177410B1 (en) 1997-12-05 2001-01-23 Vanderbilt University Therapeutic methods for prostate cancer
CA2347653A1 (en) * 1998-10-13 2000-04-20 Onyx Pharmaceuticals, Inc. Novel cell signaling polypeptides and nucleic acids
CA2435507A1 (en) * 2000-02-14 2001-08-23 Ceptyr, Inc. Improved assay for protein tyrosine phosphatases
US20040009613A1 (en) * 2001-02-16 2004-01-15 Ming-Ming Zhou Methods of identifying modulators of bromodomains
US7919276B1 (en) 2000-02-22 2011-04-05 Mount Sinai School Of Medicine ZA loops of bromodomains
US7589167B2 (en) * 2000-02-22 2009-09-15 J. David Gladstone Institutes ZA loops of bromodomains
US20040029191A1 (en) * 2002-05-17 2004-02-12 Ciphergen Biosystems, Inc. Detection of kinase substrates and products using ion mass spectrometry
EP2209893B1 (en) 2007-10-12 2013-11-20 Pronota NV Use of aptamers in proteomics
JP2011522212A (en) * 2007-10-19 2011-07-28 セル・シグナリング・テクノロジー・インコーポレイテツド Cancer classification and usage
US9115352B2 (en) 2008-03-31 2015-08-25 Sloning Biotechnology Gmbh Method for the preparation of a nucleic acid library
EP4170031A1 (en) 2012-10-23 2023-04-26 Caris Science, Inc. Aptamers and uses thereof
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
CA2895847C (en) 2012-12-19 2019-01-08 Caris Science, Inc. Compositions and methods for aptamer screening

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
NL8900529A (en) * 1989-03-03 1990-10-01 Eurodiagnostics B V METHOD AND KIT FOR DETERMINING TYROSINE PHOSPHORYLATING AND DEPHOSPHORLING ACTIVITY.
EP0567567B1 (en) * 1991-01-18 1999-12-15 New York University A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
CA2054602C (en) * 1991-10-31 2003-04-22 Anthony Pawson Method for assaying for a substance that affects an sh2-phosphorylated ligand regulatory system

Also Published As

Publication number Publication date
CA2100860C (en) 2003-11-25
US5858686A (en) 1999-01-12
AU1234692A (en) 1992-08-27
AU667803B2 (en) 1996-04-18
WO1992013001A1 (en) 1992-08-06
JP3462498B2 (en) 2003-11-05
JP3561268B2 (en) 2004-09-02
DE69230433D1 (en) 2000-01-20
US5434064A (en) 1995-07-18
CA2100860A1 (en) 1992-07-19
PT100037B (en) 1999-06-30
EP0567567A4 (en) 1994-05-11
JPH06505561A (en) 1994-06-23
ATE187772T1 (en) 2000-01-15
EP0567567B1 (en) 1999-12-15
JP2003199566A (en) 2003-07-15
US5618691A (en) 1997-04-08
IE920151A1 (en) 1992-07-29
MX9200246A (en) 1994-03-31
PT100037A (en) 1993-03-31
EP0567567A1 (en) 1993-11-03

Similar Documents

Publication Publication Date Title
EP0567567A4 (en) A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
Brown et al. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding.
McCarty et al. Regulatory Region C of theE. coliHeat Shock Transcription Factor, σ32, Constitutes a DnaK Binding Site and is Conserved Among Eubacteria
Jung et al. ATM gene product phosphorylates IκB-α
van der Geer et al. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein–protein interactions
van der Geer et al. Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin‐layer cellulose plates
Reinhard et al. VASP interaction with vinculin: a recurring theme of interactions with proline‐rich motifs
McDonald et al. Differential phosphorylation of intracellular domains of gamma-aminobutyric acid type A receptor subunits by calcium/calmodulin type 2-dependent protein kinase and cGMP-dependent protein kinase.
Mul et al. Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication
Chang et al. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA
Weinmaster et al. Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of P130gag-fps modulates its biological activity
Rodriguez et al. Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein
Pastrana et al. Overproduction and purification of protein p6 of Bacillus subtilis phage φ29: role in the initiation of DNA replication
Katagiri et al. Identification of a novel dimer stabilization region in a plant bZIP transcription activator
EP1006182A3 (en) Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs
Schumacher et al. Overlapping expression pattern of the actin organizers Spir-1 and formin-2 in the developing mouse nervous system and the adult brain
Baumann et al. The PKC targeting protein RACK1 interacts with the Epstein–Barr virus activator protein BZLF1
Collinge et al. Structure and expression of a calcium-binding protein gene contained within a calmodulin-regulated protein kinase gene
Moncman et al. Functional dissection of nebulette demonstrates actin binding of nebulin‐like repeats and Z‐line targeting of SH3 and linker domains
Verheijen et al. A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis
Park et al. Subunit structure of cell-specific E box-binding proteins analyzed by quantitation of electrophoretic mobility shift.
Moir et al. A tetratricopeptide repeat mutation in yeast transcription factor IIIC131 (TFIIIC131) facilitates recruitment of TFIIB-related factor TFIIIB70
Okamoto et al. cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF
US6365711B1 (en) Methods and reagents for modulating TGF-β superfamily signalling
Hollander et al. Localization of sites in the tail domain of the middle molecular mass neurofilament subunit phosphorylated by a neurofilament‐associated kinase and by casein kinase I

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090117